Takeda Pharmaceutical (China) Co. Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Takeda Pharmaceutical (China) Co. and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 49 Takeda Pharmaceutical (China) Co. employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Takeda Pharmaceutical (China) Co. has purchased the following applications: Microsoft Azure Cloud Services for Application Hosting and Computing Services in 2018, Microsoft Azure Monitor for Application Performance Management in 2019, Optimizely Search & Navigation (ex Episerver Find) for Application, Web and Enterprise Search in 2020 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Takeda Pharmaceutical (China) Co. is running and its propensity to invest more and deepen its relationship with Microsoft , Amazon Web Services (AWS) , Optimizely or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Takeda Pharmaceutical (China) Co. revenues, which have grown to $5.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Takeda Pharmaceutical (China) Co. intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.